Pictures are linked
to hi-res scans |
|
David
Soderlund
Credit: J. Ogrodnick – NYSAES, Cornell University |
|
|
FOR IMMEDIATE RELEASE
June 5, 2007
Contact: Linda McCandless, llm3@cornell.edu
Cornell Scientist David Soderlund
Awarded Over $2.5 Million for Toxicology Studies
by Joe Ogrodnick
GENEVA, NY: Two major research grants from the National Institute
of Environmental Health Sciences will support research on the neurotoxic
actions of insecticides in the laboratory of David Soderlund, Cornell
professor of insecticide toxicology at the New York State Agricultural
Experiment Station in Geneva, N.Y. These grants, which will provide
more than $2.5 million over five years, are among the largest single-investigator
research grants ever awarded to a member of the Experiment Station's
faculty.
The projects involve two chemical classes of insecticides that
target the sodium ion channel proteins of nerve membranes. These
proteins play a critical role in the electrical signaling of nerve
cells. This research is expected to provide new insights into mechanisms
of insecticide toxicity that will aid in assessing human health
risks associated with the use of these insecticides.
"We are extremely fortunate to have both of these projects
funded at the same time," said Soderlund. "Although each
project asks different research questions about a different chemical
class of insecticides, the main research approaches, techniques,
and tools are common to both projects. These two grants will allow
us to build a larger research team to address these issues and
should make both projects more productive than they would be individually."
For both projects, Soderlund will use cloned sodium channel genes
to turn cultured cells into synthetic nerve cells. This technique
avoids the use of experimental animals as a source of nervous tissue
and has the added benefit of giving researchers precise knowledge
of and control over the specific sodium channel proteins they are
studying.
The synthetic nerve cell approach also provides the Soderlund
laboratory with the means to address one of the most significant
problems in toxicology, the need to extrapolate insecticide risks
to humans from studies done in other organisms. "The use of
cloned genes and cell-expression systems provides us with access
to information on insecticide action on human target proteins that
is simply not available otherwise," said Soderlund.
"Landing two large grants from NIH in the presence of increased
competition nationwide and lower funding rates is huge," said
Wendell Roelofs, chair of the Department of Entomology at Geneva. "It
is a great testimony to the world-class program that Dr. Soderlund
has built up over the decades on studying the mode of action of
insecticides and developing novel methods of assessing their toxicity."
###
Link: David Soderlund's faculty
webpage
|